SCHEMBL3366231

SCHEMBL3366231

NS(=O)(=O)c1ccc(OCCCc2cccnc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.59
CA12 O43570 8/20 0.59
CA1 P00915 8/20 0.59
CA9 Q16790 8/20 0.59
CA7 P43166 4/20 0.59
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C9 P11712 2/20 0.55
TSHR P16473 2/20 0.54
SERPINE1 P05121 4/20 0.52
CA4 P22748 4/20 0.51
CA5A P35218 1/20 0.51
CA5B Q9Y2D0 1/20 0.51
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP2A6 P11509 1/20 0.49
NAMPT P43490 1/20 0.47
HRH1 P35367 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7074820 0.85 CA2 (0.68) CA2CA12CA1CA9CA7
SCHEMBL30428139 0.79 CHRNA7 (0.65) CYP3A4CYP2D6CYP2C9SERPINE1CYP2C19
SCHEMBL23291337 0.79 CHRNA7 (0.65) CYP3A4CYP2D6CYP2C9SERPINE1CYP2C19
SCHEMBL4853590 0.78 CA2 (0.50) CA2CA12CA1CA9CA7
SCHEMBL7771595 0.78 CA2 (0.50) CA2CA12CA1CA9CA7
SCHEMBL23649422 0.77 SMN1; SMN2 (0.66) CYP3A4CYP2D6CYP2C9TSHRCYP1A2
SCHEMBL9773543 0.77 CA2 (0.74) CA2CA12CA1CA9CA7
SCHEMBL7301110 0.76 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9SERPINE1CYP2A6
SCHEMBL3154669 0.76 CYP2D6 (0.58) CYP3A4CYP2D6CYP2C9SERPINE1CYP1A2
SCHEMBL11542731 0.74 TDP1 (0.66) CYP3A4CYP2D6CYP2C9TSHRSERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1335901-B1 PHARMACEUTICALLY ACTIVE SULFANILIDE DERIVATIVES MERCK SERONO SA (CH) 2010-04-14 EP disclosed